Frontlight ResearchEarly access
Peripheral artery disease trials in Bulgaria
3 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in BulgariaReducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
- Where
- Burgas, Gabrovo, Pleven, Plovdiv, Ruse, Sliven, Sofia, Sofiya, Stara Zagora, Veliko Tirnovo, Vratsa
- Age
- 18 years and over
- People
- 7,050 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07318610 · EU 2025-522954-37-00 - Phase 2/3Taking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Dobrich, Gabrovo, Lom, Montana, Plovdiv, Sliven, Smolyan, Sofia, Stara Zagora
- Age
- 18 years and over
- People
- 3,110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - No phaseTaking peopleIntegrated Approach in Frail Older People with Atrial Fibrillation
- Where
- Haskovo, Pernik, Plovdiv, Sofia
- Age
- 65 years and over
- People
- 1,250 worldwide
- Run by
- Heart Care Foundation
See details and how to joinNCT06775028